Cell and gene therapies are transforming care for certain diseases
and conditions. But innovation alone is not enough. Patients—all
patients—need fair and timely access. By aligning innovation with
access, policymakers and payers can ensure that breakthroughs in
science become breakthroughs in the lives of patients.
